z-logo
open-access-imgOpen Access
Regulatory T cells control strain specific resistance to Experimental Autoimmune Prostatitis
Author(s) -
María Laura Breser,
Andreia C. Lino,
Rubén Darío Motrich,
Gloria J. Godoy,
Jocelyne Demengeot,
Virginia Rivero
Publication year - 2016
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep33097
Subject(s) - immunology , prostatitis , autoimmune disease , context (archaeology) , autoimmunity , effector , biology , phenotype , disease , downregulation and upregulation , immune system , medicine , genetics , antibody , prostate , gene , paleontology , cancer
Susceptibility to autoimmune diseases results from the encounter of a complex and long evolved genetic context with a no less complex and changing environment. Major actors in maintaining health are regulatory T cells (Treg) that primarily dampen a large subset of autoreactive lymphocytes escaping thymic negative selection. Here, we directly asked whether Treg participate in defining susceptibility and resistance to Experimental Autoimmune Prostatitis (EAP). We analyzed three common laboratory strains of mice presenting with different susceptibility to autoimmune prostatitis upon immunization with prostate proteins. The NOD, the C57BL/6 and the BALB/c mice that can be classified along a disease score ranging from severe, mild and to undetectable, respectively. Upon mild and transient depletion of Treg at the induction phase of EAP, each model showed an increment along this score, most remarkably with the BALB/c mice switching from a resistant to a susceptible phenotype. We further show that disease associates with the upregulation of CXCR3 expression on effector T cells, a process requiring IFNγ. Together with recent advances on environmental factors affecting Treg, these findings provide a likely cellular and molecular explanation to the recent rise in autoimmune diseases incidence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here